![Anthony Manning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Manning
Directeur/Bestuurslid bij
MONTE ROSA THERAPEUTICS, INC.
Vermogen: 10 108 $ op 31-05-2026
Profiel
Momenteel is Anthony M. Manning voorzitter van Institute For Biomedical Entrepreneurship, Inc. en Chief Scientific Officer van Momenta Pharmaceuticals, Inc. Dr. Manning zit ook in de raad van bestuur van Palatin Technologies, Inc. Dr. Manning was voorheen werkzaam als SVP-Research & Preclinical Development bij Aileron Therapeutics, Inc., Vice President & Head-Autoimmune Diseases Research bij Biogen, Inc., Head-Research bij Celgene Corp., Vice President & Global Head-Inflammation bij Roche Pharmaceuticals, Inc., Principal bij Signal Pharmaceuticals, Inc. en Vice President bij Pharmacia Corp. Hij behaalde een doctoraat aan de Universiteit van Otago.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-06-2025 | 721 ( 0,04% ) | 10 108 $ | 31-05-2026 | |
| 29-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Anthony Manning
| Bedrijven | Functie | Begin |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 25-07-2023 |
Institute For Biomedical Entrepreneurship, Inc. | Oprichter | - |
Eerdere bekende functies van Anthony Manning
| Bedrijven | Functie | Einde |
|---|---|---|
| REIN THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01-04-2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01-08-2007 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01-01-2002 |
| MOMENTA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Anthony Manning
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
89
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Palatin Technologies, Inc.
 Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Institute For Biomedical Entrepreneurship, Inc. | |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Kies MarketScreener 
